Advanced Drug Delivery Reviews

Papers
(The H4-Index of Advanced Drug Delivery Reviews is 79. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Liposome composition in drug delivery design, synthesis, characterization, and clinical application411
The role of lipid components in lipid nanoparticles for vaccines and gene therapy333
Self-assembled mRNA vaccines301
COVID-19 vaccines: The status and perspectives in delivery points of view259
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives234
Supramolecular engineering of hydrogels for drug delivery215
Pharmaceutical electrospinning and 3D printing scaffold design for bone regeneration204
Overcoming barriers by local drug delivery with liposomes201
DNA hydrogel-based gene editing and drug delivery systems195
RNAi-based therapeutics and tumor targeted delivery in cancer188
Recombinant protein vaccines, a proven approach against coronavirus pandemics185
Dosing extracellular vesicles178
Translating 3D printed pharmaceuticals: From hype to real-world clinical applications174
Nucleic acid delivery for therapeutic applications161
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers160
Non-viral COVID-19 vaccine delivery systems160
Fibronectin in development and wound healing157
Connected healthcare: Improving patient care using digital health technologies154
Frontiers in the treatment of glioblastoma: Past, present and emerging150
Advances in powder bed fusion 3D printing in drug delivery and healthcare145
Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation145
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis144
Peptide and peptide-based inhibitors of SARS-CoV-2 entry139
Nanoscale MOFs: From synthesis to drug delivery and theranostics applications138
Clinical translation of nanomedicines: Challenges, opportunities, and keys134
Machine learning directed drug formulation development132
Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies132
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy131
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment129
Rational designs of in vivo CRISPR-Cas delivery systems128
Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery126
Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites126
The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives123
Antimicrobial peptides towards clinical application: Delivery and formulation122
Peptide-based supramolecular hydrogels for local drug delivery117
Approaches to surface engineering of extracellular vesicles116
Technology insight: Plant-derived vesicles—How far from the clinical biotherapeutics and therapeutic drug carriers?115
(Macro)molecular self-assembly for hydrogel drug delivery113
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery113
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment109
Polymeric drug delivery systems by additive manufacturing109
Emerging 3D printing technologies for drug delivery devices: Current status and future perspective109
Topical drug delivery: History, percutaneous absorption, and product development107
Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies106
Targeting drug delivery with light: A highly focused approach105
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge100
Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities98
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants97
The effects of protein corona on in vivo fate of nanocarriers97
Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis95
Near-infrared fluorescence imaging in immunotherapy95
Delivery of STING agonists for adjuvanting subunit vaccines95
Harnessing artificial intelligence for the next generation of 3D printed medicines95
Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases94
Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now?94
Biomedical engineering of two-dimensional MXenes94
Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms93
Why nanoparticles prefer liver macrophage cell uptake in vivo92
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network92
Microneedle-Mediated Vaccination: Innovation and Translation90
Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health90
Mesoporous silica nanoparticles for pulmonary drug delivery90
Vaccine delivery systems toward lymph nodes89
An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers89
Clinically established biodegradable long acting injectables: An industry perspective88
Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance88
Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic87
Technological advances towards extracellular vesicles mass production85
Photodynamic and antibiotic therapy in combination against bacterial infections: efficacy, determinants, mechanisms, and future perspectives85
Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles85
Let’s talk about sex: Differences in drug therapy in males and females85
Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives84
Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery84
Target specific tight junction modulators82
The past, present, and future of breast cancer models for nanomedicine development80
3D printing as a transformative tool for microneedle systems: Recent advances, manufacturing considerations and market potential80
Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems80
Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential79
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis79
0.065907955169678